🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 21 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 07/03/2007 | 42,23 | 42,79 | 41,81 | 41,85 | -1,81% | 2,30% | 12.159.001 |
| 06/03/2007 | 42,22 | 42,90 | 42,18 | 42,62 | +0,95% | 1,72% | 12.507.042 |
| 05/03/2007 | 41,93 | 42,80 | 41,68 | 42,22 | +0,14% | 2,66% | 14.573.907 |
| 02/03/2007 | 42,22 | 42,40 | 41,56 | 42,17 | +0,45% | 1,97% | 13.230.476 |
| 01/03/2007 | 41,94 | 42,44 | 41,52 | 41,98 | -0,36% | 2,21% | 13.205.953 |
| 28/02/2007 | 42,23 | 42,65 | 41,67 | 42,13 | +2,25% | 2,33% | 21.879.725 |
| 27/02/2007 | 42,25 | 42,46 | 40,41 | 41,20 | -2,92% | 4,86% | 16.185.102 |
| 26/02/2007 | 42,31 | 42,87 | 41,86 | 42,44 | +3,59% | 2,39% | 20.305.210 |
| 23/02/2007 | 41,22 | 41,24 | 40,84 | 40,97 | -0,60% | 0,97% | 9.807.813 |
| 22/02/2007 | 41,84 | 42,00 | 41,15 | 41,22 | -1,71% | 2,03% | 12.994.676 |
| 21/02/2007 | 42,41 | 42,41 | 41,80 | 41,94 | -1,24% | 1,44% | 9.869.854 |
| 20/02/2007 | 42,36 | 42,65 | 42,19 | 42,46 | +0,50% | 1,10% | 8.807.287 |
| 16/02/2007 | 42,05 | 42,70 | 41,90 | 42,25 | +0,91% | 1,91% | 14.396.690 |
| 15/02/2007 | 41,90 | 42,04 | 41,66 | 41,87 | -0,41% | 0,91% | 10.005.885 |
| 14/02/2007 | 42,12 | 42,20 | 41,89 | 42,04 | +0,25% | 0,75% | 6.874.146 |
| 13/02/2007 | 42,08 | 42,13 | 41,69 | 41,94 | +0,23% | 1,04% | 7.480.729 |
| 12/02/2007 | 41,98 | 42,21 | 41,70 | 41,84 | +0,07% | 1,23% | 9.276.896 |
| 09/02/2007 | 42,04 | 42,25 | 41,66 | 41,81 | -0,23% | 1,41% | 5.758.131 |
| 08/02/2007 | 42,00 | 42,70 | 41,80 | 41,91 | -0,77% | 2,14% | 7.576.726 |
| 07/02/2007 | 42,82 | 42,83 | 41,96 | 42,23 | -0,85% | 2,05% | 9.068.239 |
| 06/02/2007 | 42,69 | 42,73 | 42,19 | 42,60 | +0,13% | 1,27% | 8.284.126 |
| 05/02/2007 | 42,57 | 42,65 | 42,22 | 42,54 | -0,34% | 1,01% | 11.738.543 |
| 02/02/2007 | 43,05 | 43,23 | 41,90 | 42,68 | -0,89% | 3,10% | 15.398.474 |
| 01/02/2007 | 42,84 | 43,36 | 42,64 | 43,06 | +0,85% | 1,67% | 8.337.574 |
| 31/01/2007 | 42,84 | 43,02 | 42,46 | 42,70 | -0,36% | 1,31% | 10.228.585 |
| 30/01/2007 | 43,66 | 43,83 | 42,56 | 42,85 | -1,32% | 2,91% | 13.092.874 |
| 29/01/2007 | 44,07 | 44,11 | 43,23 | 43,43 | -1,04% | 1,99% | 7.784.125 |
| 26/01/2007 | 43,88 | 44,27 | 43,34 | 43,88 | -0,02% | 2,11% | 7.392.906 |
| 25/01/2007 | 43,90 | 44,42 | 43,63 | 43,89 | -0,48% | 1,80% | 8.482.512 |
| 24/01/2007 | 43,68 | 44,21 | 43,59 | 44,10 | +1,07% | 1,42% | 6.476.011 |